Ming-Chun Lai

1.6k total citations · 2 hit papers
15 papers, 1.4k citations indexed

About

Ming-Chun Lai is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Ming-Chun Lai has authored 15 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Cancer Research and 3 papers in Epidemiology. Recurrent topics in Ming-Chun Lai's work include Cancer-related molecular mechanisms research (3 papers), Liver Disease Diagnosis and Treatment (2 papers) and MicroRNA in disease regulation (2 papers). Ming-Chun Lai is often cited by papers focused on Cancer-related molecular mechanisms research (3 papers), Liver Disease Diagnosis and Treatment (2 papers) and MicroRNA in disease regulation (2 papers). Ming-Chun Lai collaborates with scholars based in China, Madagascar and Taiwan. Ming-Chun Lai's co-authors include Shusen Zheng, Haiyang Xie, Liming Wu, Feng Zhang, Lin Zhou, Zhe Yang, Qianqian Zhu, Lin Zhou, Chunyang Xing and Zhe Yang and has published in prestigious journals such as Journal of Vascular Surgery, Annals of Surgical Oncology and Laboratory Investigation.

In The Last Decade

Ming-Chun Lai

15 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Overexpression of Long Non-coding RNA HOTAIR Predicts Tumor Recurrence in Hepatocellular Carcinoma Patients Following Liver Transplantation

2011 618 citations Zhe Yang, Lin Zhou et al. Annals of Surgical Oncology profile →
Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation

2011 507 citations Ming-Chun Lai, Zhe Yang et al. Medical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ming-Chun Lai China	9	1.2k	1.1k	145	104	78	15	1.4k
Shuai Guo China	15	611 0.5×	510 0.5×	41 0.3×	39 0.4×	76 1.0×	41	788
Yu Qi China	17	693 0.6×	629 0.6×	69 0.5×	92 0.9×	57 0.7×	34	889
Daniela Pollutri Italy	10	654 0.6×	618 0.6×	89 0.6×	45 0.4×	30 0.4×	14	858
Shupeng Liu China	8	448 0.4×	425 0.4×	71 0.5×	47 0.5×	28 0.4×	10	661
Mingjun Sun China	18	640 0.5×	542 0.5×	121 0.8×	83 0.8×	108 1.4×	34	931
Haolin Yun China	12	430 0.4×	233 0.2×	192 1.3×	70 0.7×	16 0.2×	13	617
Luming Zheng China	12	859 0.7×	912 0.8×	128 0.9×	56 0.5×	176 2.3×	24	1.2k
Shaowei Mo China	12	412 0.4×	318 0.3×	46 0.3×	44 0.4×	43 0.6×	15	575
Chung Wah Wu Hong Kong	13	633 0.5×	609 0.6×	85 0.6×	18 0.2×	87 1.1×	18	905

Countries citing papers authored by Ming-Chun Lai

Since Specialization

Citations

This map shows the geographic impact of Ming-Chun Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming-Chun Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming-Chun Lai more than expected).

Fields of papers citing papers by Ming-Chun Lai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming-Chun Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming-Chun Lai. The network helps show where Ming-Chun Lai may publish in the future.

Co-authorship network of co-authors of Ming-Chun Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Ming-Chun Lai. A scholar is included among the top collaborators of Ming-Chun Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming-Chun Lai. Ming-Chun Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Xi, Bin, Fangzhou Luo, Bin He, et al.. (2022). High nuclear ABCG1 expression is a poor predictor for hepatocellular carcinoma patient survival. Hepatobiliary & pancreatic diseases international. 21(4). 370–377. 10 indexed citations

Lai, Ming-Chun, et al.. (2022). MicroRNA-561-5p Inhibits Cell Proliferation and Invasion by Targeting RAC1 in Pancreatic Ductal Adenocarcinoma.. PubMed. 52(2). 213–221. 1 indexed citations

Zhu, Qianqian, Ming-Chun Lai, Xun Wang, et al.. (2021). LncRNA SNHG15 relieves hyperglycemia-induced endothelial dysfunction via increased ubiquitination of thioredoxin-interacting protein. Laboratory Investigation. 101(9). 1142–1152. 12 indexed citations

Lai, Ming-Chun, Lei Geng, Shusen Zheng, & Junfang Deng. (2021). Laparoscopic ultrasound-guided superselective portal vein injection combined with real-time indocyanine green fluorescence imaging and navigation for accurate resection of localized intrahepatic bile duct dilatation: a case report. BMC Surgery. 21(1). 328–328. 2 indexed citations

Lai, Ming-Chun, Qianqian Zhu, Jun Xu, & Wenjin Zhang. (2021). Experimental and clinical evidence suggests that GRPEL2 plays an oncogenic role in HCC development.. American Journal of Cancer Research. 11(9). 4175–4198. 9 indexed citations

Lai, Ming-Chun, Jiangshan Lian, Wenjin Zhang, et al.. (2019). Compare with safety and efficacy of entecavir and adefovir dipivoxil combination therapy and tenofovir disoproxil fumarate monotherapy for chronic hepatitis B patient with adefovir-resistant. Mathematical Biosciences & Engineering. 17(1). 627–635. 3 indexed citations

Ye, Yufu, Wei Wang, Weichen Zhang, et al.. (2019). Galectin-1 attenuates hepatic ischemia reperfusion injury in mice. International Immunopharmacology. 77. 105997–105997. 10 indexed citations

Lai, Ming-Chun, Qianqian Zhu, Kwabena Gyabaah Owusu-Ansah, et al.. (2017). Prognostic value of Rho GDP dissociation inhibitors in patients with hepatocellular carcinoma following liver transplantation. Oncology Letters. 14(2). 1395–1402. 1 indexed citations

Zhang, Wu, Haiyang Xie, Songming Ding, et al.. (2016). CADM1 regelates the G1/S transition and represses tumorigenicity through the Rb-E2F pathway in hepatocellular carcinoma. Hepatobiliary & pancreatic diseases international. 15(3). 289–296. 21 indexed citations

10.

Zhu, Qianqian, Donglin Li, Ming-Chun Lai, et al.. (2015). Endovascular treatment of isolated abdominal aortic dissection and postoperative aortic remodeling. Journal of Vascular Surgery. 61(6). 1424–1431. 19 indexed citations

11.

Lai, Ming-Chun, Wei Zhang, Wu Zhang, et al.. (2014). First case report of isolated penile mucormycosis in a liver transplantation recipient. International Journal of Infectious Diseases. 29. 208–210. 8 indexed citations

12.

Wei, Chiu‐Chi, et al.. (2013). Assignment of project members considering capability and personality balance. Kybernetes. 42(7). 1016–1028. 3 indexed citations

13.

Yang, Zhe, Lin Zhou, Liming Wu, et al.. (2011). Overexpression of Long Non-coding RNA HOTAIR Predicts Tumor Recurrence in Hepatocellular Carcinoma Patients Following Liver Transplantation. Annals of Surgical Oncology. 18(5). 1243–1250. 618 indexed citations breakdown →

14.

Lai, Ming-Chun, Zhe Yang, Lin Zhou, et al.. (2011). Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Medical Oncology. 29(3). 1810–1816. 507 indexed citations breakdown →

15.

Zhu, Qianqian, Lin Zhou, Zhe Yang, et al.. (2011). O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation. Medical Oncology. 29(2). 985–993. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact